FLGT News and Press, Fulgent Genetics Inc. From 11/09/20

Fulgent Genetics, Inc. (FLGT) Q3 2020 Results Earnings Conference Call November 9, 2020, 4:30 PM ET Company Participants Nicole Borsje - Head, Investor Relations Ming Hsieh - Chief Executive Officer Paul Kim - Chief Financial Officer Brandon Perthuis - Chief Commercial Officer Conference Call...

Fulgent Genetics, Inc. (FLGT) Q3 2020 Earnings Conference Call November 9, 2020 4:20 PM ET Company Participants Nicole Borsje - Head, IR Ming Hsieh - Chief Executive Officer Brandon Perthuis - Chief Commercial Officer Paul Kim - Chief Financial Officer Conference Call Participants Rachel Vatn...

Fulgent Genetics (FLGT): Q3 Non-GAAP EPS of $2.08 beats by $1.53; GAAP EPS of $1.98 beats by $1.50.Revenue of $101.7M (+882.6% Y/Y) beats by $53.24M.Q4 guidance: Revenue of ~$110M vs consensus of $58.5M.FY20 guidance: Revenue of $235M from previous guidance of $135M vs consensus of $131.9M.Sh...

Third Quarter 2020 Results : Record Revenue of $101.7 million, growing more than 880% year-over-year Record Billable tests delivered approximately 1.04 million, growing more than 4,800% year-over-year Gross Margin improved approximately 19 percentage points sequentia...

Gainers: Sundial Growers (SNDL) +79%.Aptevo Therapeutics (APVO) +60%.AMC Entertainment (AMC) +60%.Ashford Hospitality Trust (AHT) +58%.Cinemark Holdings (CNK) +56%.National CineMedia (NCMI) +48%.Tuniu (TOUR) +41%.EPR Properties (EPR) +41%.Dave & Buster's Entertainment (PLAY) +40%.Bro...

Biogen BIIB -28% after FDA advisory committee snub of Alzheimer’s drug.Quidel (QDEL) -26%.HighPoint Resources HPR -25% on Q3 earnings release.Co-Diagnostics CODX -24%.Enlivex Therapeutics (ENLV) -21%.Liquidia Technologies LQDA -20% on Q3 earnings...

Fulgent has a successful genetic testing business growing at 50% that should benefit from the reduced cost of sequencing. However, more recently, Fulgent's COVID-19 business has seen greater success and is expected to quadruple total revenue this year. Comparing Fulgent with compa...

TEMPLE CITY, Calif., Oct. 26, 2020 (GLOBE NEWSWIRE) -- Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent Genetics” or the “company”) today announced that it will release its third quarter 2020 financial results after the market closes on Monday November 9, 2020. Th...

Fulgent Genetics (FLGT) inks an agreement with the Ohio Department of Rehabilitation and Correction for COVID-19 testing for its 14K employees.The deal includes on-site self-collections at locations across the state. Samples will be sent to Fulgent's lab for processing and reporting within 24...

TEMPLE CITY, Calif., Sept. 30, 2020 (GLOBE NEWSWIRE) -- Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent Genetics” or the “company”), a technology company providing comprehensive testing solutions through its scalable technology platform, today announced that the ...